Professor of Medicine, University VA School of Medicine
Nephrology
Dr. Mark D. Okusa, MD
|
|
Give Review
Mark Okusa works in the field of Nephrology. He studied medicine at Yale University School of Medicine. Yale University School of Medicine is a one of the best medicals schools. Yale University School of Medicine has a rank of 7 in research and a 57 in primary care He received 3 awards: "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification" and "Fellow (ASNF)". Mark Okusa is a published doctor and has 100 publications published. The lastest was: 'Regulation of adenylyl cyclase in polarized renal epithelial cells by G protein-coupled receptors.' Mark D. Okusa accepts Medicare.
Publications
- Endothelial Sphingosine 1‑Phosphate Receptor‑1 Mediates Protection and Recovery from Acute Kidney Injury.
- Renal Hemodynamics in AKI: In Search of New Treatment Targets.
- Therapeutic Targets of Human AKI: Harmonizing Human and Animal AKI.
- Natural IgM Switches the Function of Lipopolysaccharide-Activated Murine Bone Marrow-Derived Dendritic Cells to a Regulatory Dendritic Cell That Suppresses Innate Infl...
- Outpatient Dialysis for Patients With AKI: A Policy Approach to Improving Care.
- Recovery from Acute kidney injury: predicting outcomes.
- Hepcidin Mitigates Renal Ischemia-Reperfusion Injury by Modulating Systemic Iron Homeostasis.
- Ultrasound Modulates the Splenic NeuroImmune Axis in Attenuating AKI.
- Emerging Therapeutic Targets of Sepsis-Associated Acute Kidney Injury.
- Pharmacological management of fluid overload.
- Identification of a novel mitochondrial uncoupler that does not depolarize the plasma membrane.
- Natural IgM Anti-leucocyte Autoantibodies (IgM-ALA) Regulate Inflammation Induced by Innate and Adaptive Immune Mechanisms.
- Potential use of biomarkers in Acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference.
- Expanding role of T cells in Acute kidney injury.
- Acute kidney injury in the cancer patient.
- A basic science view of Acute kidney injury biomarkers.
- Regulatory T Cells in AKI.
- Role of interleukin 23 signaling in Clostridium difficile colitis.
- Reading between the (guide)lines-the KDIGO practice guideline on Acute kidney injury in the individual patient.
- AKI: A Path Forward.
- Dendritic cells in Acute kidney injury: cues from the microenvironment.
- Acute kidney injury due to 'coral reef syndrome'.
- Dendritic Cell Sphingosine 1-Phosphate Receptor-3 Regulates Th1-Th2 Polarity in Kidney Ischemia-Reperfusion Injury.
- Dying Cells and Extracellular HiStones in AKI: Beyond a NET Effect?
- Autocrine Adenosine Signaling Promotes Regulatory T Cell-Mediated Renal Protection.
- Role of leukocytes in the pathogenesis of Acute kidney injury.
- Natural IgM Anti-Leukocyte Autoantibodies Attenuate Excess Inflammation Mediated by Innate and Adaptive Immune Mechanisms Involving Th-17.
- Monocyte/Macrophage Chemokine Receptor CCR2 Mediates Diabetic Renal Injury.
- Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes.
- Pathogenesis of Acute Kidney Injury: Foundation for Clinical Practice.
- Dangers within: DAMP responses to damage and cell death in Kidney disease.
- Natural Killer T Cell-Derived IL-17 Mediates Lung Ischemia-Reperfusion Injury.
- Lessons from Haiti on disaster relief.
- Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury.
- Macrophages, dendritic cells, and Kidney ischemia-reperfusion injury.
- Regulatory T cells contribute to the protective effect of ischemic preconditioning in the Kidney.
- IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse Kidney ischemia-reperfusion injury.
- Regulatory T cells suppress innate immunity in Kidney ischemia-reperfusion injury.
- Compartmentalization of neutrophils in the kidney and lung following Acute ischemic kidney injury.
- Divergent roles of sphingosine kinases in Kidney ischemia-reperfusion injury.
- The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in Kidney ischemia-reperfusion injury.
- Evaluation and initial management of Acute kidney injury.
- Naturally occurring IgM anti-leukocyte autoantibodies (IgM-ALA) inhibit T cell activation and chemotaxis.
- Activation of adenosine 2A receptors preserves structure and function of podocytes.
- Cardiac surgery as a cause of Acute kidney injury: pathogenesis and potential therapies.
- Distant organ injury following Acute kidney injury.
- NKT cell activation mediates neutrophil IFN-gamma production and Renal ischemia-reperfusion injury.
- Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition.
- Pharmacologic treatment of Acute kidney injury: why drugs haven't worked and what is on the horizon.
- Ultrasound Contrast Agents in the Study of Kidney Function in Health and Disease.
- Targeting sphingosine 1 phosphate receptor type 1 receptors in Acute kidney injury.
- Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse Kidney.
- Adenosine A2A receptor activation attenuates inflammation and injury in Diabetic nephropathy.
- Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-gamma.
- The renin-angiotensin system and its blockade in diabetic renal and cardiovascular Disease.
- Correction of renal hypertension after Kidney transplantation from a donor with Gitelman syndrome.
- Acute kidney injury associated with cardiac surgery.
- T cells and T-cell receptors in Acute renal failure.
- Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF.
- A2A adenosine receptors on bone marrow-derived cells protect liver from ischemia-reperfusion injury.
- Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages.
- Polymorphoneutrophilic infiltration in Acute interstitial nephritis of Sjögren syndrome.
- Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction.
- Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells.
- Selective blockade of lysophosphatidic acid LPA3 receptors reduces murine Renal ischemia-reperfusion injury.
- Combination therapy with angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in the treatment of patients with type 2 Diabetes mellitus.
- Takayasu arteritis presenting as a pulmonary-Renal syndrome.
- Coccidioidomycosis meningitis and syndrome of inappropriate antidiuretic hormone.
- A(2A) adenosine receptor: a novel therapeutic target in renal Disease.
- Physiological biomarkers of Acute kidney injury: a conceptual approach to improving outcomes.
- The role of inflammation in the cardio-Renal syndrome: a focus on cytokines and inflammatory mediators.
- The role of tubuloglomerular feedback in the pathogenesis of Acute kidney injury.
- Impact of Acute kidney injury on chronic kidney disease and its progression.
- Targeting of adenosine receptors in ischemia-reperfusion injury.
- Immune mechanisms and novel pharmacological therapies of Acute kidney injury.
- Naturally occurring IgM anti-leukocyte autoantibodies inhibit T-cell activation and chemotaxis.
- The changing pattern of Acute kidney injury: from one to multiple organ failure.
- Nephron Physiology. Foreword.
- Inflammation in Acute kidney injury.
- The nexus of Acute kidney injury, chronic kidney disease, and World Kidney Day 2009.
- Management of cirrhotic ascites: physiological basis of diuretic action.
- Blocking the immune response in ischemic Acute kidney injury: the role of adenosine 2A agonists.
- Synthesis and biological evaluation of gamma-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists.
- Technology Insight: biomarker development in Acute kidney injury--what can we anticipate?
- A2A adenosine receptor agonist and PDE4 inhibition delays inflammation but fails to reduce injury in experimental obstructive Nephropathy.
- The inflammatory cascade in Acute ischemic renal failure.
- Tinnitus suppression by electrical promontory stimulation in sensorineural deaf patients.
- Effects of discrimination difficulty on cognitive event-related brain potentials in patients With cochlear implants.
- Hearing recovery in sudden deafness patients using a modified defibrinogenation therapy.
- [Statistical analysis of recovery from sudden deafness among treatment groups].
- Electrically evoked auditory brainstem Response.
- Regulation of adenylyl cyclase in polarized Renal epithelial cells by G protein-coupled receptors.
- Selective A2A adenosine receptor activation reduces ischemia-reperfusion injury in rat Kidney.
- Immunohistochemical localization of alpha 2A-adrenergic receptors in catecholaminergic and other brainstem neurons in the rat.
- Regulation of rat Renal alpha 2 B-adrenergic receptors by potassium depletion.
- Apical membrane and intracellular distribution of endogenous alpha 2A-adrenergic receptors in MDCK cells.
- Clinical manifestations and management of Acute lithium intoxication.
- Active potassium absorption by the Renal distal tubule.
- Effect of Na-channel blockers and lumen Ca on K secretion by rat Renal distal tubule.
Schools
Virginia Commonwealth University School Of Medicine
Med College Va
Yale University School Of Med
Procedures Preformed
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Glomerulonephritis
- Acute Kidney Failure
- Alkalosis
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Fellow (ASNF)
Education
-
Yale University School of Medicine -
Virginia Commonwealth University Health System -
Virginia Commonwealth University School of Medicine
Hospital
-
University of Virginia Medical Center
Drug Facts
| NPI NUMBER | 1679618763 | |
| NPPES Provider LastName | OKUSA | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 229080001 | |
| NPPES Provider State | VA | |
| Specialty Description | Nephrology | |
| Total Claim Count | 173.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1679618763 |
| Last Name Of The Provider | OKUSA |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
Dr. Rasheed Balogun, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Uta Erdbruegger, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Daphne M. Harrington, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joshua D. King, MD |
|
|
Dr. Mitchell H. Rosner, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Amy J. Mangrum, MD |
|
|
Dr. James R. Freeman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thu H. Le, MD |
|
|
Dr. Mary O. Muoneke, MD |